
Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …

GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …

British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines. The new facility …

British multinational GlaxoSmithKline has been rated as the third best company to work for in the UK, according to jobs …

GlaxoSmithKline’s workforce on President’s Island in Memphis, US, is set to see the loss of 99 employees, as revealed in …

GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …

OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec …

As Hurricane Florence begins to breach the Southeast Coast, major pharma firms have announced they are enacting contingency plans, including …

GlaxoSmithKline has suffered a regulatory blow in the label expansion of its interleukin-5 (IL5) inhibitor Nucala (mepolizumab), with the FDA …

GlaxoSmithKline has announced its intention to cut 650 employees from its current US workforce, with the cutbacks coming as part …

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …

Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted …

A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK …

British multinational GlaxoSmithKline has announced the closure of its manufacturing facilities in Sligo, Ireland. The company is set to wind …